NO910403L - Fremgangsmaate for fremstilling av farmasoeytisk preparat. - Google Patents

Fremgangsmaate for fremstilling av farmasoeytisk preparat.

Info

Publication number
NO910403L
NO910403L NO91910403A NO910403A NO910403L NO 910403 L NO910403 L NO 910403L NO 91910403 A NO91910403 A NO 91910403A NO 910403 A NO910403 A NO 910403A NO 910403 L NO910403 L NO 910403L
Authority
NO
Norway
Prior art keywords
procedure
pharmaceutical preparation
layer
preparing pharmaceutical
active medicament
Prior art date
Application number
NO91910403A
Other languages
English (en)
Other versions
NO910403D0 (no
Inventor
Majid Mahjour
Edwards Eonchao Linn
Bernadette Mauser
Zahra Rashidbaigi
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32512850&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO910403(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to IE39089A priority Critical patent/IE62871B1/en
Priority to ZA891031A priority patent/ZA891031B/xx
Priority to NZ228094A priority patent/NZ228094A/xx
Priority to AU30258/89A priority patent/AU611771B2/en
Priority to PH38267A priority patent/PH26548A/en
Priority to JP5306989A priority patent/JP2939264B2/ja
Priority to DK198901096A priority patent/DK175621B1/da
Priority to AT89104017T priority patent/ATE90571T1/de
Priority to EP89104017A priority patent/EP0332147B1/en
Priority to ES89104017T priority patent/ES2056981T3/es
Priority to DE89104017T priority patent/DE68907081T2/de
Priority to US07/391,808 priority patent/US5019395A/en
Priority claimed from ZA91624A external-priority patent/ZA91624B/xx
Priority to ZA91624A priority patent/ZA91624B/xx
Priority to NZ236921A priority patent/NZ236921A/en
Priority to AU70061/91A priority patent/AU634015B2/en
Priority to IE30591A priority patent/IE64308B1/en
Priority to CA002035143A priority patent/CA2035143A1/en
Priority to FI910455A priority patent/FI910455A7/fi
Publication of NO910403D0 publication Critical patent/NO910403D0/no
Priority to KR1019910001750A priority patent/KR100191456B1/ko
Priority to NO91910403A priority patent/NO910403L/no
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Priority to JP3038921A priority patent/JPH04338325A/ja
Priority to PT96779A priority patent/PT96779B/pt
Priority to AT91102354T priority patent/ATE114481T1/de
Priority to DK91102354.7T priority patent/DK0499662T3/da
Priority to ES91102354T priority patent/ES2064780T3/es
Priority to DE69105480T priority patent/DE69105480T2/de
Priority to EP91102354A priority patent/EP0499662B1/en
Publication of NO910403L publication Critical patent/NO910403L/no
Priority to GR950400229T priority patent/GR3014988T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Physical Water Treatments (AREA)
  • Laminated Bodies (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
NO91910403A 1988-03-08 1991-02-01 Fremgangsmaate for fremstilling av farmasoeytisk preparat. NO910403L (no)

Priority Applications (28)

Application Number Priority Date Filing Date Title
IE39089A IE62871B1 (en) 1988-03-08 1989-02-07 Compositions with enhanced penetration
ZA891031A ZA891031B (en) 1988-03-08 1989-02-09 Compositions with enhanced penetration
NZ228094A NZ228094A (en) 1988-03-08 1989-02-22 Transmembranally administerable compositions containing bioaffecting agent and gelling agent
AU30258/89A AU611771B2 (en) 1988-03-08 1989-02-23 Compositions with enhanced penetration
PH38267A PH26548A (en) 1988-03-08 1989-03-01 Compositions with enhanced penetration
DE89104017T DE68907081T2 (de) 1988-03-08 1989-03-07 Mittel mit erhöhtem Penetrationsvermögen.
DK198901096A DK175621B1 (da) 1988-03-08 1989-03-07 Præparater med forbedret penetration
JP5306989A JP2939264B2 (ja) 1988-03-08 1989-03-07 浸透強化組成物
AT89104017T ATE90571T1 (de) 1988-03-08 1989-03-07 Mittel mit erhoehtem penetrationsvermoegen.
EP89104017A EP0332147B1 (en) 1988-03-08 1989-03-07 Compositions with enhanced penetration
ES89104017T ES2056981T3 (es) 1988-03-08 1989-03-07 Composiciones dotadas de una capacidad de penetracion mejorada.
US07/391,808 US5019395A (en) 1988-03-08 1989-08-09 Compositions with enhanced penetration
ZA91624A ZA91624B (en) 1991-01-28 1991-01-28 Delivery device for compositions with enhanced penetration and process for preparing same
NZ236921A NZ236921A (en) 1988-03-08 1991-01-28 Laminate for transmembranal administration of a drug
CA002035143A CA2035143A1 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
AU70061/91A AU634015B2 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
IE30591A IE64308B1 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
FI910455A FI910455A7 (fi) 1988-03-08 1991-01-30 Parannetun läpäisevyyden omaava koostumus
KR1019910001750A KR100191456B1 (ko) 1988-03-08 1991-02-01 침투력이 향상된 조성물
NO91910403A NO910403L (no) 1988-03-08 1991-02-01 Fremgangsmaate for fremstilling av farmasoeytisk preparat.
JP3038921A JPH04338325A (ja) 1988-03-08 1991-02-12 増強された浸透性を有する組成物
PT96779A PT96779B (pt) 1988-03-08 1991-02-15 Laminado composito de duas camadas
EP91102354A EP0499662B1 (en) 1988-03-08 1991-02-19 Compositions with enhanced penetration
DE69105480T DE69105480T2 (de) 1988-03-08 1991-02-19 Mittel mit erhöhtem Penetrationsvermögen.
AT91102354T ATE114481T1 (de) 1988-03-08 1991-02-19 Mittel mit erhöhtem penetrationsvermögen.
DK91102354.7T DK0499662T3 (da) 1988-03-08 1991-02-19 Præparater med forøget penetration
ES91102354T ES2064780T3 (es) 1988-03-08 1991-02-19 Composiciones con penetracion mejorada.
GR950400229T GR3014988T3 (en) 1988-03-08 1995-02-08 Compositions with enhanced penetration.

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US16532288A 1988-03-08 1988-03-08
NZ236921A NZ236921A (en) 1988-03-08 1991-01-28 Laminate for transmembranal administration of a drug
ZA91624A ZA91624B (en) 1991-01-28 1991-01-28 Delivery device for compositions with enhanced penetration and process for preparing same
AU70061/91A AU634015B2 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
IE30591A IE64308B1 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
CA002035143A CA2035143A1 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
FI910455A FI910455A7 (fi) 1988-03-08 1991-01-30 Parannetun läpäisevyyden omaava koostumus
KR1019910001750A KR100191456B1 (ko) 1988-03-08 1991-02-01 침투력이 향상된 조성물
NO91910403A NO910403L (no) 1988-03-08 1991-02-01 Fremgangsmaate for fremstilling av farmasoeytisk preparat.
JP3038921A JPH04338325A (ja) 1988-03-08 1991-02-12 増強された浸透性を有する組成物
PT96779A PT96779B (pt) 1988-03-08 1991-02-15 Laminado composito de duas camadas
EP91102354A EP0499662B1 (en) 1988-03-08 1991-02-19 Compositions with enhanced penetration

Publications (2)

Publication Number Publication Date
NO910403D0 NO910403D0 (no) 1991-02-01
NO910403L true NO910403L (no) 1992-08-03

Family

ID=32512850

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91910403A NO910403L (no) 1988-03-08 1991-02-01 Fremgangsmaate for fremstilling av farmasoeytisk preparat.

Country Status (16)

Country Link
EP (2) EP0332147B1 (no)
JP (2) JP2939264B2 (no)
KR (1) KR100191456B1 (no)
AT (2) ATE90571T1 (no)
AU (2) AU611771B2 (no)
CA (1) CA2035143A1 (no)
DE (2) DE68907081T2 (no)
DK (2) DK175621B1 (no)
ES (2) ES2056981T3 (no)
FI (1) FI910455A7 (no)
GR (1) GR3014988T3 (no)
IE (2) IE62871B1 (no)
NO (1) NO910403L (no)
NZ (2) NZ228094A (no)
PH (1) PH26548A (no)
PT (1) PT96779B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE62871B1 (en) * 1988-03-08 1995-03-08 Warner Lambert Co Compositions with enhanced penetration
EP0523150A4 (en) * 1990-04-06 1993-09-29 Pharmetrix Corporation Device and method for enhanced administration of physostigmine
DE4334919A1 (de) * 1993-10-13 1995-04-20 Liedtke Pharmed Gmbh Grenzwertig wirksame Arzneiformen mit Betablockern
FI971752A7 (fi) * 1994-10-24 1997-04-24 Nikken Chemicals Co Ltd Ihonalaisesti annettava valmiste
DE19533089C1 (de) * 1995-09-07 1997-05-22 Hexal Ag Tacrin-Pflaster
DE19533772C1 (de) * 1995-09-12 1998-01-02 Hexal Ag Tacrin/Selegilin-Pflaster
US7094422B2 (en) 1996-02-19 2006-08-22 Acrux Dds Pty Ltd. Topical delivery of antifungal agents
US6929801B2 (en) 1996-02-19 2005-08-16 Acrux Dds Pty Ltd Transdermal delivery of antiparkinson agents
US6916487B2 (en) 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of antiemetics
US6916486B2 (en) 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of analgesics
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US6998138B2 (en) 1996-02-19 2006-02-14 Acrux Dds Pty. Ltd. Topical delivery of anti-alopecia agents
US6923983B2 (en) 1996-02-19 2005-08-02 Acrux Dds Pty Ltd Transdermal delivery of hormones
US6646379B1 (en) 1998-12-25 2003-11-11 Matsushita Electric Industrial Co., Ltd. Metal vapor discharge lamp having cermet lead-in with improved luminous efficiency and flux rise time
DK1137407T3 (da) * 1998-12-11 2004-05-10 Bakulesh Mafatlal Khamar Fremgangsmåde til fremstilling af en formulering af topisk beta-blokkere med forbedret effektivitet
DE10004790B4 (de) * 2000-02-01 2004-09-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung von Zaleplon, Verfahren zu seiner Herstellung und seine Verwendung
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
FR2870125B1 (fr) * 2004-05-12 2010-03-26 Dermaconcept Jmc Formulation du type spot-on utile en cosmetologie et en dermatologie
TR201815853T4 (tr) 2005-10-12 2018-11-21 Besins Healthcare Sarl Hipogonadizmin tedavisinde kullanıma yönelik geliştirilmiş testosteron jeli.
JP5052558B2 (ja) * 2009-04-03 2012-10-17 ロート製薬株式会社 ゲル軟膏

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513011A (en) * 1981-10-23 1985-04-23 L'oreal Composition in the form of a shampoo based on anthralin
DE3333639A1 (de) * 1983-09-17 1985-03-28 Dynamit Nobel Ag Zubereitung von nitroestern fuer die koronartherapie
US4649075A (en) * 1984-08-09 1987-03-10 Leonora Jost Transdermal and transmucosal vortexed foam devices and the method of making
ATE77962T1 (de) * 1985-02-25 1992-07-15 Univ Rutgers Dosierungssystem fuer transdermale absorption von arzneimittelwirkstoffen.
US4816456A (en) * 1986-10-01 1989-03-28 Summers William K Administration of monoamine acridines in cholinergic neuronal deficit states
AU607172B2 (en) * 1986-12-22 1991-02-28 Cygnus, Inc. Diffusion matrix for transdermal drug administration
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
IE62871B1 (en) * 1988-03-08 1995-03-08 Warner Lambert Co Compositions with enhanced penetration

Also Published As

Publication number Publication date
KR920016085A (ko) 1992-09-24
ES2056981T3 (es) 1994-10-16
EP0499662B1 (en) 1994-11-30
ATE114481T1 (de) 1994-12-15
DE69105480D1 (de) 1995-01-12
IE890390L (en) 1989-09-08
IE910305A1 (en) 1992-07-29
DK109689A (da) 1989-09-09
DE68907081D1 (de) 1993-07-22
ATE90571T1 (de) 1993-07-15
EP0332147A3 (en) 1990-09-19
GR3014988T3 (en) 1995-05-31
AU611771B2 (en) 1991-06-20
AU634015B2 (en) 1993-02-11
AU7006191A (en) 1992-08-20
FI910455A0 (fi) 1991-01-30
EP0499662A1 (en) 1992-08-26
PH26548A (en) 1992-08-19
JPH01272519A (ja) 1989-10-31
NZ236921A (en) 1993-08-26
DE68907081T2 (de) 1993-10-21
CA2035143A1 (en) 1992-07-30
PT96779A (pt) 1992-08-31
EP0332147A2 (en) 1989-09-13
FI910455L (fi) 1992-07-31
ES2064780T3 (es) 1995-02-01
JPH04338325A (ja) 1992-11-25
DE69105480T2 (de) 1995-04-06
NZ228094A (en) 1991-09-25
DK0499662T3 (da) 1995-05-15
DK175621B1 (da) 2004-12-27
JP2939264B2 (ja) 1999-08-25
AU3025889A (en) 1989-09-14
IE62871B1 (en) 1995-03-08
PT96779B (pt) 1998-09-30
DK109689D0 (da) 1989-03-07
IE64308B1 (en) 1995-07-26
FI910455A7 (fi) 1992-07-31
NO910403D0 (no) 1991-02-01
EP0332147B1 (en) 1993-06-16
KR100191456B1 (ko) 1999-06-15

Similar Documents

Publication Publication Date Title
NO910403D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk preparat.
AU4540389A (en) Quinuclidines, their use as medicaments and processes for their preparation
NZ228637A (en) Solid state laminated composite for administering fentanyl
DE3774148D1 (de) Im magen verbleibende granula.
ES2041238T3 (es) Matriz de difusion para la administracion de medicamento por via percutanea y dispositivo de administracion de medicamento por via percutanea que los incluye.
NO912470D0 (no) Fremgangsmaate til fremstilling av et komposittlag paa et underlag i et apparat som inneholder elektrolytt i fast tilstand.
DE3677131D1 (de) Laminate und aus diesen hergestellte formen.
EP0413034A4 (en) Poultice and preparation thereof
NO902851D0 (no) Fremgangsmaate for fremstilling av 5,11-dihydro-6h-dipyrido(3,2-b:2',3'-e) (1,4) diazepin-6-oner og -tioner.
CA2082768A1 (en) Diagonal veneer laminate
DK330386D0 (da) Lagen, sengetaeppe eller lignende genstand til paasaetning paa en madras
IE842355L (en) Invalid chair based on composite materials.
IT8722032A0 (it) Composizioni farmaceutiche laminate transdermali ad effetto prolungato e procedimento per la loro preparazione.
NO892871D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO883973D0 (no) Lateks, anvendelig som klebemiddel, laminat hvori lateksen inngaar, samt fremgangsmaate for fremstilling av lateks og laminat.
Stella et al. Curable Rubber Composition
DE3860778D1 (de) Flammhemmende harzzusammensetzung und damit hergestelltes laminat.
ITRM920754A0 (it) Procedimento per la preparazione di materiali compositi, simili ai graniti e marmi naturali e prodotto risultante.
DK692387A (da) Landingsstelmekanisme med et omloebsventilaggregat til at reducere stoeddaempningskraefterne under koersel paa jorden
NO880841D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
IT8821313V0 (it) Dispositivo di bloccaggio per rotelle di poltrone scrivanie e simili.